Results 81 to 90 of about 29,283 (148)

A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI [PDF]

, 2015
BackgroundA thorough understanding of the patient's genotype and their functional response to a medication is necessary for improving event free survival.
Chidambaram, Sundar, Das, Brajraj, Dikshit, Byomakesh, Jain, Jugnu, Khandrika, Lakshmipathi, Mahalingam, Mohanshankar, Naik, Sudhir, Rath, P.C., Rath, Pallavi, Sahoo, Prashant K.   +9 more
core   +2 more sources

Seguridad e interacciones de los Inhibidores de la Bomba de Protones (IBP) [PDF]

, 2009
Los IBP han demostrado ser fármacos relativamente seguros después de muchos años de una amplia utilización. Las reacciones adversas con las que más frecuentemente se han asociado son leves y con escasa repercusión clínica.
Esplugues Mota, Juan Vicente
core  

Enantiomers of methylenedioxy designer drugs : the role of cytochrome P450s and catechol-O-methyltransferase in their metabolism [PDF]

, 2009
In the presented studies, the CYP dependent, enantioselective N-dealkylation and demethylenation of the designer drugs MDMA (Ecstasy), MBDB (Eden), and MDEA (Eve) was investigated.
Meyer, Markus Robert
core  

Coadministration of Lopinavir/Ritonavir and Phenytoin Results in Two-Way Drug Interaction Through Cytochrome P-450 Induction

Journal of Acquired Immune Deficiency Syndromes, 2004
Michael L. Lim, S. Min, J. Eron, R. Bertz, M. Robinson, A. Gaedigk, A. Kashuba   +6 more
semanticscholar   +1 more source

Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agent [PDF]

, 2014
Acimovic J, Bernhardt R, Kocjan D, Kuzman D, Kóbori László, Kőhalmy Krisztina, Monostory Katalin, Pascussi JM, Rozman D, Szabó Pál Tamás, Temesvári Manna, Wilzewski B   +11 more
core   +1 more source

Contribution of human cytochrome P‐450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine

British Journal of Pharmacology, 2003
J. Wójcikowski, L. Pichard‐Garcia, P. Maurel, W. Daniel   +3 more
semanticscholar   +1 more source

Interaction of Modified Cyclodextrins with Cytochrome P-450

Bioscience, biotechnology and biochemistry, 2005
M. Ishikawa, H. Yoshii, T. Furuta
semanticscholar   +1 more source

Cardiovascular Pharmacogenomics: Current Status and Future Directions—Report of a National Heart, Lung, and Blood Institute Working Group [PDF]

, 2012
Boineau, Robin, Bristow, Michael R., Hasan, Ahmed A. K., McCaffrey, Timothy A., Musunuru, Kiran, Newton-Cheh, Christopher Holmes, Paltoo, Dina N., Roden, Dan M., Rosenberg, Yves, Wohlgemuth, Jay G., Zineh, Issam   +10 more
core   +2 more sources

Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay. [PDF]

Sci Rep
Priyadharshini A, Vijayakumar TM, Damodharan N, Vasanth KM, Elaiyaraja A.   +4 more
europepmc   +1 more source

Development and Characterization of pFluor50, a Fluorogenic-Based Kinetic Assay System for High-Throughput Inhibition Screening and Characterization of Time-Dependent Inhibition and Inhibition Type for Six Human CYPs. [PDF]

Molecules
Shriwas P, Revnew A, Roo S, Bender A, Miller K, Hadad CM, Lane TR, Ekins S, McElroy CA.   +8 more
europepmc   +1 more source